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Fibroblasts are a main player in the tumor-inhibitory microenvi-
ronment. Upon tumor initiation and progression, fibroblasts can
lose their tumor-inhibitory capacity and promote tumor growth.
The molecular mechanisms that underlie this switch have not been
defined completely. Previously, we identified four proteins over-
expressed in cancer-associated fibroblasts and linked to Rho GTPase
signaling. Here, we show that knocking out the Ras homolog family
member A (RhoA) gene in normal fibroblasts decreased their tumor-
inhibitory capacity, as judged by neighbor suppression in vitro and
accompanied by promotion of tumor growth in vivo. This also in-
duced PC3 cancer cell motility and increased colony size in 2D cul-
tures. RhoA knockout in fibroblasts induced vimentin intermediate
filament reorganization, accompanied by reduced contractile force
and increased stiffness of cells. There was also loss of wide F-actin
stress fibers and large focal adhesions. In addition, we observed a
significant loss of α-smooth muscle actin, which indicates a difference
between RhoA knockout fibroblasts and classic cancer-associated
fibroblasts. In 3D collagen matrix, RhoA knockout reduced fibro-
blast branching and meshwork formation and resulted in more
compactly clustered tumor-cell colonies in coculture with PC3
cells, which might boost tumor stem-like properties. Coculturing
RhoA knockout fibroblasts and PC3 cells induced expression of
proinflammatory genes in both. Inflammatory mediators may in-
duce tumor cell stemness. Network enrichment analysis of tran-
scriptomic changes, however, revealed that the Rho signaling
pathway per se was significantly triggered only after coculturing
with tumor cells. Taken together, our findings in vivo and in vitro
indicate that Rho signaling governs the inhibitory effects by fi-
broblasts on tumor-cell growth.
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The tumor microenvironment consists of various cells andextracellular matrix (ECM) proteins, which together form the
tumor stroma. This stroma differs from normal tissue in that it
is highly enriched in ECM proteins, which form fibrous net-
works that provide scaffolds for tumor-cell proliferation and
migration. Defective organization and composition of the ECM
can thus influence tumor growth and metastasis (1–4). The
architecture of the stroma mainly depends on the composition
of the ECM and the mechanical and biochemical functions of
fibroblasts (5).
Fibroblasts can inhibit growth of cancer cells (6, 7). The ECM
and soluble factors that are secreted upon fibroblast–tumor cell
contact drive the fibroblast inhibitory effects (8). However, this
inhibitory activity of fibroblasts can be lost, and even reversed, to
provide an opposing tumor stimulatory activity during tumor
development (9). In parallel, fibroblasts activate proinflammatory
gene expression (10). These activatory fibroblasts are often referred
to as cancer- or carcinoma-associated fibroblasts (CAFs), and they
have been suggested to promote tumor growth and metastasis
through remodeling of the ECM network and cytokine and che-
mokine secretion (11).
Small Rho GTPases control the shape and mechanical and
adhesive properties of fibroblasts (12). Most notably, RhoA (Ras
homolog family member A) has been shown to induce assembly
of focal adhesions and F-actin stress fibers, and to control the
shape and adhesive and contractile properties of fibroblasts, as
well as their capacity to organize the ECM (13, 14). CAFs often
express myofibroblast markers, such as α-smooth muscle actin
(α-SMA). We recently identified 12 markers that are highly
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expressed in cancer-associated stroma and not in normal stroma
(15). Four of these markers, DLG1, ROCK2, ARHGAP31, and
ARHGAP26, are linked to Rho GTPase signaling. In that study,
we also identified the known CAF marker ACTA2 (encodes
α-SMA), which is regulated by the Rho GTPase signaling path-
way (16–19). This link to the Rho pathway prompted us to hy-
pothesize that RhoA signaling in fibroblasts mediates their
capacity to control tumor growth.
Recent findings have indicated that an actomyosin-based
contractile force in fibroblasts is required for CAFs to remodel
the ECM (20). The stiffness of the extracellular environment can
activate RhoA in fibroblasts, which leads to increased expression
of (the CAF marker) α-SMA and differentiation into myofibro-
blasts (16, 17, 19). In line with this, Calvo et al. have suggested that
CAFs can increase the stiffness of the ECM to stimulate the for-
mation of CAFs, which results in a feed-forward, self-reinforcing
loop, through which CAFs can promote tumorigenesis (20).
Taken together, these observations suggested that tumor
growth and invasion is shaped by cross-talk between mechanical
and biochemical signaling, which is modulated by RhoA signal-
ing in fibroblasts. Therefore, targeting this pathway in fibroblasts
might influence their tumor-inhibition capacity.
Results
RhoA Is Required for the Tumor-Inhibitory Capacity of Fibroblasts in
Vitro and in Vivo. To determine whether RhoA affects the tumor-
regulatory capacity of fibroblasts, we ablated RhoA in Bj human
telomerase reverse transcriptase (BjhTERT) fibroblasts. Endogenous
RhoA expression in control fibroblasts and significant loss of RhoA
gene and protein expression in RhoA knockout (KO) BjhTERT fi-
broblasts was confirmed by quantitative RT-PCR (qRT-PCR) (P <
10−6) (Fig. 1A and Fig. S1A) and Western blotting (Fig. 1B).
To determine the regulatory capacity of these fibroblasts on
tumor cells, proliferation of PC3 prostate cancer cells was
measured in vitro in monocultures and in cocultures with either
control or RhoA-KO fibroblasts. Consistent with previous re-
ports (6), coculture with control fibroblasts dramatically de-
creased PC3 cell growth (Fig. 1C), whereas RhoA-KO fibroblasts
showed significantly decreased inhibition of PC3 cell growth,
compared with control fibroblasts (P < 10−10) (Fig. 1C and Figs.
S1B and S2).
We then asked whether this RhoA deficiency of fibroblasts
can also regulate tumor-cell growth in vivo in SCID or SCID-
beige mice. Here, 2 ×104 PC3 cells were injected subcutaneously
alone and in combination with 1 ×106 of either control or RhoA-
KO fibroblasts. Across three repeated experiments, this relatively
low number of PC3 cells alone did not induce any detectable tu-
morigenic response in the 9 wk following their injection. Coinjection
of control fibroblasts with PC3 cells resulted in the formation of one
small tumor in one of the five mice in two of the three experiments
(Fig. 1D and Fig. S3). However, all of the mice injected with PC3
cells plus RhoA-KO fibroblasts developed tumors (Fig. 1D and Fig.
S3) across the three experiments. After prolonged initiation over
the initial 6 to 7 wk, these subcutaneous tumors then grew extremely
rapidly, reaching volumes of up to 1 cm3 within the following 2 wk
(Fig. 1D). These experiments demonstrate that fibroblasts that lack
RhoA do not inhibit tumor-cell growth both in vitro and in vivo.
In the following sections, we report on our investigation into
how the RhoA KO in these BjhTERT fibroblasts altered cell
morphology and dynamics, gene expression, and the impact of
RhoA KO on the signaling network.
RhoA-KO Fibroblasts Induce Tumor-Cell Motility and Proliferation. To
study the mode of interaction of RhoA-KO fibroblasts with tu-
mor cells, we examined the differences in the motility of PC3
mRFP cells (PC3 cells stably expressing monomeric red fluorescent
protein) in coculture with control and RhoA-KO fibroblasts using
total internal reflection fluorescence (TIRF) microscopy for live-cell
time-lapse imaging. PC3 mRFP cell motility was recorded for
65 h, with these 65 (hourly) time points subdivided into five
color-coded trajectories whereby each corresponded to 13 h of
recording. Similar to their effect on PC3 cell proliferation in
A
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Fig. 1. Loss of RhoA in human fibroblasts reduces their tumor-inhibitory
capacity in vitro and induces their tumor-stimulatory capacity in vivo.
(A) qRT-PCR for RhoA expression in BjhTERT, BjhTERT–cont-cas9, and
BjhTERT RhoA-KO fibroblasts. The y axis indicates the values of expression
level of RhoA gene normalized to the TBP reference gene. The x axis shows
the cDNA samples. Data are means with 0.95 confidence intervals. ***P =
0.00029 (one-way ANOVA with three levels). (B) Representative Western
blots of BjhTERT, BjhTERT–cont-cas9 and BjhTERT RhoA-KO fibroblasts, for
RhoA protein levels in total cell lysate (as indicated). Actin protein levels are
shown as loading control. (C) Inhibitory capacity of BjhTERT–cont-cas9 and
BjhTERT RhoA-KO fibroblasts as confluent monolayers (4-d-old) tested in
coculture with PC3 mRFP prostate cancer cells. Data are proliferation ratios
of PC3 mRFP cells after 6 d coculture with fibroblasts. ***P < 10−10. (D) Tumor
volumes in SCID mice injected with mixtures of PC3 mRFP cells with BjhTERT–
cont-cas9 fibroblasts or BjhTERT RhoA-KO fibroblasts (as indicated). PC3 mRFP
alone and with BjhTERT fibroblasts did not form tumors (not shown for clarity).
Data are means of three independent experiments. ***P < 10−10. See details
and statistical analysis in Fig. S3.
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vitro, the inhibitory effect of fibroblasts on cell motility of
PC3 was significantly decreased upon knocking out the RhoA
gene in fibroblasts (P = 0.0037) (Fig. 2 and Movies S1 and
S2). Furthermore, in the RhoA-KO fibroblast cocultures, PC3
mRFP cells formed larger colonies than when cocultured with
control fibroblasts, as measured by the distribution of the PC3
mRFP cells over a given area (Fig. S4 and Movies S3 and S4).
Consistent with the contact-dependent neighbor suppression
described by Alkasalias et al. (8), early contacts at the be-
ginning of the cocultures between the fibroblasts and PC3
mRFP cells were essential to inhibit tumor-cell proliferation
and motility. Remarkably, this inhibition was lost with the
RhoA KO/deficiency of the RhoA-KO fibroblasts (Movies S5
and S6).
Altered Cytoskeleton and Adhesion Structures in RhoA-KO Fibroblasts
Are Linked to Changes in Cellular Contractile Force and Stiffness.
Control and RhoA-KO fibroblasts were examined under im-
munofluorescence microscopy, where the RhoA deficiency
resulted in less regularly shaped cells compared with those of
control fibroblasts (Fig. 3). Furthermore, RhoA-KO fibroblasts
showed less formation of wide actin stress fibers and fewer distinct,
dense, and large focal adhesions (Fig. 3A). RhoA-KO fibroblasts
also showed significant reduction in α-SMA expression (Fig. S5).
Furthermore, the structure of vimentin intermediate filaments in
RhoA-KO cells appeared less organized, and in a more homog-
enous distribution of very thin and long filament extensions
throughout the cell cytoplasm (Fig. 3B).
To determine whether this altered cytoskeleton structure of
RhoA-KO fibroblasts was associated with changes in the me-
chanical properties of these cells, their contractile force and
stiffness were measured using traction force and atomic force
microscopy, respectively. Compared with control fibroblasts,
RhoA-KO fibroblasts showed significantly reduced contractile
forces (P = 0.004) (Fig. 4A). In contrast, the cell stiffness, here
represented by the elastic modulus determined via indentation of
the cells, was more homogenous and more evenly distributed for
RhoA-KO fibroblasts than control fibroblasts (Fig. 4B). When
the cell areas were analyzed in detail, RhoA-KO fibroblasts
appeared significantly stiffer than control fibroblasts (P =
0.0196) (Fig. 4 C and D). RhoA-KO fibroblasts also showed
lower numbers of very soft locations, compared with control fi-
broblasts (Fig. 4 B and C).
Fig. 2. RhoA-KO fibroblasts induce tumor-cell motility and proliferation. Live-cell TIRF microscopy imaging. (A) Trajectories of PC3 mRFP prostate cancer cells during
13-h intervals. Color-coded images show a 65-h time-point projection of the red-labeled tumor cells: yellow (1–13 h), green (14–26 h), magenta (27–39 h), blue (40–52
h), and red (53–65 h). (B) Maximum projection of all five color-coded images showing the total motility (full trajectories) of the PC3 mRFP tumor cells over the 65 h. (C)
Kinetics of tumor-cell motility. Motility of tumor cells quantified by calculation of the areas of the cell trajectories, normalized for mean number of cells in each 13-h
interval. **P = 0.0037. (D) Mean number of PC3 mRFP cells that proliferated during each 13-h interval (of five time points). See also Movies S1 and S2.
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Coculture of RhoA-KO Fibroblasts with Cancer Cells Activates
Proinflammatory Genes and Rho-Related Pathway Activity. To
identify factors that might mediate the tumor promoting effects
of RhoA-KO fibroblasts, gene-expression analysis was per-
formed for RhoA-KO fibroblasts and PC3 mRFP prostate can-
cer cells before coculturing and after 6 d of coculturing, using the
Affymetrix Whole Transcript Assay platform and validation of
selected genes using the qPCR technique on newly generated
samples.
After coculture with PC3 mRFP cells, the RhoA-KO fibroblasts
manifested higher expression levels of such proinflammatory sig-
nature genes as IL-1A, IL-1B, IL-6, IL-8, chemokine (C-C motif)
ligand 2 (CCL2), and TNF-α–induced protein 2 (TNFAIP2) (Table
S1) (10, 21). In contrast, in the control fibroblasts expression of
genes for proinflammatory cytokines did not seem to change after
the coculturing. In turn, the PC3 cells that were cocultured with
RhoA-KO fibroblasts exhibited higher expression of certain genes
of proinflammatory signature (IL-6, IL-8, and CCL2) (Table S2),
compared with the PC3 cells cocultured with control fibroblasts.
To increase the power of our analysis, we further applied the
network enrichment analysis (NEA) (22). Similarly to the gene-
set enrichment analysis of differential expression (DE), NEA can
summarize observations by raising them to the pathway level.
However, it is more powerful than the former method because of
considering network connections between differentially expressed
and pathway genes, so that the latter may be identified even when
their own expression is not changed (23).
Both the control and RhoA-KO fibroblasts were sampled
before and after coculturing with the PC3 prostate cancer cells.
Using Venn diagram sampling and NEA tools available at https://
www.evinet.org, we created lists of genes that were differentially
expressed between the control and RhoA-KO fibroblasts as mea-
sured before (Datasets S1 and S2) and after (Datasets S3 and S4),
or both before and after (Datasets S5 and S6) coculturing them with
the PC3 cells. Separating DE genes into up- and down-regulated
fractions produced six gene lists in total. Unexpectedly, the “up”
and “down” gene lists specifically before the coculturing (Fig. 5,
UP_BEFORE, DOWN_BEFORE) did not manifest any significant
network connections toward Rho signaling pathways. Re-
markably though, the latter pathways appeared significantly con-
nected to a set of 55 genes that were consistently up-regulated with
the fibroblast and cancer cell coculturing (Fig. 5, UP_BOTH).
Similarly, the Rho pathways were enriched in connections to the
gene sets specifically up-regulated and down-regulated following the
coculturing (Fig. 5, UP_AFTER, DOWN_AFTER). As an example,
we looked at details of functional connections with the mDia-SRF
pathway, which is known for its involvement in actin modifications
and thus appeared potentially implicated in the consequences of our
RhoA KO. At the gene-expression level, we observed that neither
serum response factor (SRF) nor other relevant genes were altered
because of the knockout. However, in network enrichment analysis
this pathway functionally linked to the UP_BOTH, UP_AFTER,
and DOWN_AFTER lists (Fig. 5). We could see that the most
central, significantly linked gene was SRF itself, with a potential
Fig. 3. RhoA-KO fibroblasts show altered cytoskeletal organization and cell-
matrix adhesion. Representative images showing phosphotyrosine (pY) (green)
(A), vimentin (B), and F-actin (red) (A and B) in the control and RhoA-KO fibro-
blasts (as indicated). Images are representative of at least three independent
experiments. Arrows indicate large focal adhesions linked to stress fibers (A) and
the spatial organization of the vimentin filaments (B). (Scale bars, 20 μm.)
4.0x10-6
A
B
C D
BjhTERT-cont-cas9                
C
el
lu
la
r c
on
tra
ct
ile
 fo
rc
e 
(J
)
**
***
Young's  Modulus
D
en
si
ty
1.0x105
3.0x10-6
2.0x10-6
1.0x10-6
0.0
2.0x105 4.0x105 5.0x1053.0x1050.0
BjhTERT-RhoA-KO
BjhTERT
cont-cas9
BjhTERT
RhoA-KO
BjhTERT
cont-cas9
BjhTERT
RhoA-KO
BjhTERT-cont-cas9
BjhTERT-RhoA-KO
Fig. 4. Altered cellular contractile forces and cell stiffness of tumor-stimu-
latory fibroblasts. (A) Contractile forces of individual control (dots) and
RhoA-KO (squares) fibroblasts. The P value indicates a difference of 0.004.
**P > 0.01. (B) Image showing the Young’s modulus of the locations over the
control (Left) and RhoA-KO (Right) fibroblasts. Lighter colors indicate higher
modulus. (C) Density plot showing distribution of the measured stiffness for
values of individual locations of measurement within the physiological
range of 0 kPA to 75 kPa, for 33,505 data points from control fibroblasts, and
33,505 data points from RhoA-KO fibroblasts. (D) Boxplot showing distri-
butions and median values of measured stiffness for values within the
physiological range of 0 kPa to 75 kPa, including 33,505 data points for
control fibroblasts, and 33,505 data points for RhoA-KO fibroblasts. Data for
the RhoA-KO cells show significantly higher stiffness. ***P < 2.2e-16.
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involvement of the other genes presented by Gopinath et al. (24)
and Geneste et al. (25).
Our observations suggest that the Rho-related transcriptome
changes caused by the RhoA KO emerged mainly during the
coculturing with the tumor cells rather than preexisting in the fi-
broblasts before this procedure (i.e., in the PC3-naive fibroblasts).
RhoA-KO Fibroblasts Support a Growth Pattern of Compact Tumor
Clusters and Cell Contacts in 3D Collagen Cocultures. To un-
derstand how the changes in the fibroblast Rho pathways, gene-
expression programs, contact-dependent neighbor suppression,
and cytoskeleton that were induced by the RhoA KO and
coculturing in vitro relate to the increased PC3 tumorigenesis in
vivo, we established a 3D coculture model of the BjhTERT fi-
broblasts and PC3 mRFP prostate cancer cells. Equal numbers
of control (BjhTERT cont-cas9) and RhoA-KO fibroblasts alone
or in combination with PC3 mRFP cells were embedded in the
3D collagen matrix and (co)cultured for 7 d. In the 3D mono-
cultures, control fibroblasts formed dense cross-networks with
branching and elongated sprouting. Consistent with the cytoskeletal
changes in 2D cultures, for RhoA-KO fibroblast 3D monocultures,
fluorescence imaging of filamentous actin revealed impaired
stress fibers in conjunction with less sprouting, as a blunt-ended
phenotype (Fig. 6A). In the cocultures for RhoA-KO fibro-
blasts, the PC3 mRFP cells grew in clusters surrounded by these
fibroblasts, and showed compact positioning of their nuclei,
whereas both PC3 cells and fibroblasts were more dispersed in
the control fibroblast cocultures (Fig. 6B). To quantify this
compactness versus dispersal of PC3 tumor cells in the fibro-
blast cocultures, we generated a “Clustering Index.” PC3 cells
cocultured with RhoA-KO fibroblasts had a significantly higher
Clustering Index compared with PC3-cell and control-fibroblast
cocultures (Fig. 6C). These results suggest that by driving actin-
cytoskeleton–dependent fibroblast branching, RhoA signaling can
support coincident dispersal of the cocultured tumor cells. There-
fore, in the 3D microenvironment, RhoA ablation in fibroblasts can
promote the delayed tumor growth by supporting tumor-cell survival
and stem-like properties via cell–cell contacts, altered Rho path-
ways, and interactions with (or the close distance of) the fibroblasts
with increasing chemokine production (i.e., by mechanical and
biochemical mechanisms).
Discussion
Although interactions between a tumor and the stroma are
regulated by various biochemical reactions, it is becoming in-
creasingly clear that mechanical cues also have a significant role
in these interactions (26). In the present study, we have shown
that these RhoA-KO fibroblasts that are characterized by altered
gene-expression profile, cytoskeleton, and mechanical properties
can promote tumor growth, although they do not show common
markers of CAFs.
Indeed, our experimental model was different from any other
model that studied CAFs. Here, we show that normal inhibitory
fibroblasts can be switched into a promoting subtype before they
become CAFs by the classic definition. Our cells showed that
RhoA ablation had an immediate “net effect” on the interaction
between fibroblasts and cancer cells. In other words, this effect
of fibroblasts apparently was not induced by the cells’ co-
existence and coevolution during extended time periods.
Here, we investigated the proliferation and migration of the
metastatic PC3 prostate cancer cell line in cocultures with fi-
broblasts in vitro and in a subcutaneous tumor xenograft model
in mice. A loss of the tumor-inhibitory capacity of these fibro-
blasts upon RhoA ablation was observed in these 2D systems and
in the xenograft tumors. Interestingly, in the presence of RhoA-
KO fibroblasts in the 3D collagen system, the PC3 tumor cells
formed colonies that were prominently compact clusters with
closely positioned nuclei. This might be the underlying cause of
the growth of the tumor xenografts in this study, whereby the
tumor cells coinjected with RhoA-KO fibroblasts started to grow
after a long lag-phase, to form subcutaneous tumors. We suggest
that the cluster-like aggregation and ample homotypic cancer-
cell contacts in the presence of RhoA-KO fibroblasts in this 3D
system are linked to the tumor propagating and stem-like
properties. Furthermore, in the in vivo xenograft model, low
numbers of tumor cells were enough to initiate tumor growth
when they were in the presence of RhoA-KO fibroblasts, with
Fig. 5. Network enrichment of differentially expressed genes in pathways related to RhoA regulation. Global patterns in regard to pathways related to Rho
signaling. Connectivity between DE lists and individual genes of the SRF–mDia pathway. Rounded boxes: lists of differentially expressed genes; AFTER,
after coculturing; BEFORE, before coculturing; BOTH, both before and after coculturing; DOWN, down-regulation because of RhoA knock-out of
≥twofold; N, number of genes in list; UP, up-regulation due to RhoA KO of ≥ twofold. Circles: pathways; the size reflects the number of member genes,
the color indicates the relative activity in the global network (total number of links). Double-headed arrows summarize individual gene–gene con-
nections (in either direction, and undirected ones) in the global network between any differentially expressed genes and any pathway members.
Numeric labels give numbers of individual gene–gene network connections behind the arrows. Only arrows corresponding to significant network
enrichment are shown (adjusted P < 0.05). The lists of the genes in each group are given in Datasets S1–S6. The data on the SRF–mDia pathway are
shown as described previously (24, 25).
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the emergence of palpable tumors delayed, both of which are
known hallmarks of tumor-propagating cells.
Our findings indicate that upon coculturing, the transcriptomes
of both the RhoA-KO fibroblasts and the tumor cells are shaped
by activation of the proinflammatory signature. It is known that
inflammation promotes cancer growth and metastasis (27, 28).
Thus, this RhoA KO might provide a link between inflammation
and cancer via the induction of a proinflammatory environment.
The observed increase of tumor-cell motility in the presence of
the RhoA-KO fibroblasts is in line with previous observations
that proinflammatory chemokines can promote tumor-cell mi-
gration (27). In addition, the increased PC3 cell motility appears
to be because of the present finding that upon RhoA loss, these
RhoA-KO fibroblasts lose their contact-dependent neighbor-
suppression effects.
The observed RhoA-mediated orchestration of many different
biochemical and physical factors makes RhoA a “master-regu-
lator” of interactions between tumors and stroma (26). Cyto-
skeletal filaments in the cell can convert mechanical signals into
biochemical signals via the mechano-sensitive proteins of the
cell. In this way, the extracellular and intracellular mechanical
properties of the cells can activate different downstream pro-
cesses, such as cell migration, adhesion, gene transcription, and
differentiation (29). Furthermore, these RhoA-KO tumor-pro-
moting fibroblasts showed significant reduction in α-SMA ex-
pression. Such concordant down-regulation can be explained via
the regulation of smooth muscle cell-specific promoter activity of
the α-SMA gene through RhoA signaling (30).
We observed that the RhoA-KO fibroblasts showed increased
homogeneous stiffness, with fewer soft locations, and decreased
contractile forces. This is in line with the previous observations
that RhoA is a key regulator of the mechanical properties of
fibroblasts (31–33). These mechanical changes in the RhoA-KO
fibroblasts were linked to the loss of wide stress fibers and large
focal adhesions. De Wever et al. proposed that fibroblasts in the
tumor microenvironment can behave as particularly motile units,
which can invade the cancer-cell compartment (34), potentially
because of the altered cytoskeleton of these cells (35). In line
with the mechanical control of tumor growth by fibroblasts in the
tumor microenvironment, Kumar and Weaver suggested that
mechanical forces have a major role in the onset and progression
of cancers (5). In addition, based on the literature in the field,
Karagiannis et al. proposed a working model for how mechanical
and adhesive properties of fibroblasts govern local cancer growth
(36 and references therein). In their model, the fibroblasts in
tumors show altered cell-matrix adhesion, increased migration,
and changed mechanics, which might stimulate cancer cells to
migrate toward stromal regions that are less dense, and thereby
increase the size of a tumor. Moreover, cell-matrix stiffness has
been shown to stimulate cytokinesis, which suggests that the in-
creased stiffness of the surrounding fibroblasts can also stimulate
the proliferation of cancer cells (37). These ideas are in line with
our findings that these RhoA-KO tumor-promoting fibroblasts
showed increased homogeneous stiffness and fewer soft loca-
tions, with altered cytoskeleton and cell-matrix adhesion.
Tumor cells go through many changes, both phenotypically
and genetically, as they pass through the different stages of
initiation, growth, invasion, colonization, and metastasis. This
might be true for the fibroblasts in the tumor microenvironment
A
B
C
Fig. 6. Growth of PC3 tumor cells with RhoA-KO fibroblasts in 3D collagen.
(A) Phenotypes of control (cont-cas9) and RhoA-KO BjhTERT fibroblasts
cultured for 7 d in the 3D type I collagen matrix. Arrows indicate differences
in sprouting ability between control and RhoA-KO fibroblasts. Higher
magnifications and arrowheads indicate elongated sprouting in control
compared with RhoA-KO fibroblasts with the blunt-ended phenotype. (B) To
assess growth of PC3 tumor cells with RhoA-KO fibroblasts in 3D collagen,
equal numbers of PC3mRFP cells and BjhTERT control or RhoA-KO fibroblasts
were suspended as single cells into 3D collagen and cultured for 7 d.
(C) Clustering Index calculated to quantify the spreading and compactness of
growth of PC3 tumor spheres in coculture with RhoA-KO fibroblasts. For the
Clustering Index, the number of sprouting growths was calculated (total n =
16 image fields from two independent repeats) and subtracted from a
constant value: Clustering Index = [20 − (mean number of sprouting
growths)] ×5. (Scale bars, 200 μm.)
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too. As we have shown here, the mere RhoA KO do not yet turn
normal fibroblasts into full-scale CAFs, even though their phe-
notype shifts from inhibitory to noninhibitory and then into tumor-
promoting cells. Thus, although not being classic CAFs, the
fibroblasts acquired key properties that proved to be sufficient
for promotion of tumor-cell growth.
The loss of α-SMA and reduction of contractile forces in these
RhoA-KO fibroblasts was another difference from CAFs. Therefore,
they might respond differently to certain signals, including RhoA
signaling. Importantly, we found that knocking out RhoA in
normal fibroblasts did not activate significant relations to the
Rho signaling pathway until these fibroblasts met the tumor
cells. This might be highly relevant in the context of tumor ini-
tiation and early development.
We have demonstrated that fibroblasts with ablated RhoA lose
their normal inhibitory capacity in vitro, induce tumor growth in
vivo and migration and proliferation of tumor cells in vitro, and
support clustering of cocultured tumor cells in a 3D system. In the
light of these results, RhoA appears to be an important regulator of
the switch from tumor-inhibitory to tumor-promoting fibroblasts.
The regulatory effects on tumor-cell growth must be imposed via a
complex course of mechanical and biochemical reactions. An aspect
here that remains elusive to the scope of the present study is how
the loss of RhoA (which alters the mechanical and biochemical
properties of normal stromal fibroblasts) can trigger a stem-like
phenotype in these PC3 prostate cancer cells. Probably, increased
level of proinflammatory genes plays role in inducing the expression
of stemness-related properties of tumor cells (38, 39). We have
demonstrated that loss of RhoA changed the cytoskeleton, the
contractile forces and cell stiffness of the cells, induced a proin-
flammatory state, and interfered with Rho signaling cascades.
However, further studies are needed to determine if the RhoA
levels in stromal fibroblast govern the carcinoma aggressiveness and
the clinical outcome.
Conclusions
Our findings suggest that RhoA controls the tumor-inhibitory
capacity of fibroblasts through their mechanical properties and
biochemical signaling. It also appears that a significant part of
the RhoA-dependent signaling is activated by the presence of
these tumor cells. A more detailed identification of the molec-
ular mechanisms that underlie this intercellular control is a
promising area for future studies.
Materials and Methods
RhoA CRISPR/Cas and Lentivirus System. We prepared lentiviral CRISPR/Cas9
vectors that coexpressed Streptococcus pyogenes Cas9, PuroR, and a human
U6 promoter driving expression of anti-RhoA guideRNAs (40). The gene-
specific regions of the guideRNA sequences were designed by the CRISPR
design tool from the Zhang laboratory (crispr.mit.edu/), and their sequences
were: RhoA_1, GAACTATGTGGCAGATATCG; RhoA_2, GACAGCCCTGATA-
GTTT; and RhoA_3, GCTGCCATCCGGAAGAAAC. The lentiviruses were gen-
erated using standard third-generation packaging vectors in 293T cells. In
addition, we constructed an empty lentiviral control vector.
Established RhoA KO BjhTERT Fibroblast Line. We transduced three BjhTERT
clones of different origin: BjhTERT (original), BjhTERT-C (crossy), and BjhTERT-W
(whirly) (6), with the RhoA lentiviral CRISPR/Cas9 vector. A mixture of the three
vectors (i.e., RhoA_1, RhoA_2, and RhoA_3) was used to transduce the fibro-
blasts in the presence of Polybrene. In parallel to the KO line, a negative
control BjhTERT fibroblast line was generated using the empty lentiviral vec-
tor. The cells were selected with 2 μg/mL puromycin. A polyclonal line was
collected and subcultured, and the status of RhoA at the protein level was
evaluated using Western blotting.
RT-PCR Analysis. Quantitative real-time PCR protocol is described in SI Ma-
terials and Methods. qPCR data were analyzed using the reference genes
TBP. Each reaction was repeated three times.
Ct values were determined for the internal control (glyceraldehyde-3-
phosphate dehydrogenase or TATA-binding protein) and for the test genes at
the same threshold level in the exponential phase of the PCR curves. Relative
quantification [comparative Ct (ΔΔCt) method] was used to compare the
expression level of the test genes with the internal control. Dissociation
curve analysis was performed after every run to check the specificity of
the reaction.
Western Blotting.Anti-RhoAantibody (Cat. no. sc-418; SantaCruzBiotechnology)
and anti–α-SMA antibody (Cat. no. M0851; Dako) were used. The protocol is
described in SI Materials and Methods.
Tumor-Inhibitory Capacity Assay. Tumor-cell proliferation on fibroblast
monolayers was analyzed in 384-well plates. Fibroblasts were plated in 100 μL
cell-culture medium [IMDM; 10% (vol/vol) FBS, PSG] and cultured for 5 d,
during which time they formed confluent monolayers. After the formation
of full confluent monolayers, 80 μL medium was removed and 200 H2AmRFP-
labeled PC3 prostate cancer cells (PC3 mRFP cells) were plated on top of the
fibroblast monolayers in 80 μL cell-culture medium. The control wells con-
tained 200 labeled tumor cells without the fibroblast monolayers.
Microscopy, Image Analysis, and Quantification. Immunofluorescence micros-
copy, automatic microscopy, and analysis of the tumor-cell numbers were
carried out at the single-cell level using an automated microscope system, as
previously described (6, 41, 42).
Coinjection of Tumor Cells and Fibroblasts in SCID and SCID-Beige Mice. A
nontumorigenic number of PC3 prostate cancer cells (2 × 104 cells) (43, 44)
were injected subcutaneously alone or when mixed with fibroblasts (1 × 106
cells) into 4-wk-old female SCID or SCID-beige mice (Taconik). Each mouse
received one injection. The occurrence and growth of tumors were then ana-
lyzed up to 80-d postinjection. The procedures using the SCID and SCID-beige
mice were approved by the North Stockholm Ethical Committee (Decision no.
192/14). Ten mice were used for the experiments. The mice were monitored for
tumor growth twice a week, with the tumors measured using a caliper (mm3).
TIRF Microscopy Live-Cell Motility Assay. Fibroblasts were seeded into six-well
plates, with 70,000 BjhTERT control or BjhTERT RhoA-KO fibroblasts cultured
in each well, for 18–24 h. Each fibroblast culture was cocultured with 5,000
PC3 mRFP prostate cancer cells, with the coculture then kept in the incubator
for another 24 h. The next day, each well was washed and supplemented
with fresh medium. The plates were then relocated to the TIRF microscope
incubation chamber, at constant 37 °C and under 5% (vol/vol) CO2. The ZEN2
Software was used to design the experiment and guided the complete mi-
croscopic unit automatically. The time-lapse imaging was recorded for 65 h,
with a 1-h interval per capture. A field of 25 images (5 × 5) that covered a
total area of 4.118 × 3.085 mm2 was captured using the 10× objective lens.
Three-Dimensional Growth Assays. Collagenmatrix was prepared by dissolving
rat-tail collagen I (Sigma-Aldrich) in 0.3% acetic acid, with this neutralized
with NaOH and diluted to a final concentration of 2.25 mg/mL in MEM on ice
(45). Single-cell suspensions of 5,000 H2AmRFP-plasmid expressing PC-3 cells
and 5,000 control or RhoA-KO fibroblasts were prepared in IMDM supple-
mented with 10% (vol/vol) FBS, GlutaMAX (Gibco), and 100 U/mL penicillin-
streptomycin. The cells were rapidly mixed with collagen gels and casted in
48-well plates (Nunclon Delta Surface, Thermo Scientific). The cultures were
incubated in an incubator at 37 °C and 5% (vol/vol) CO2 for 7 d and fixed
with 4% (vol/vol) PFA for 1 h at room temperature. Three-dimensional
matrices were stained with phalloidin-Alexa488 to analyze PC-3 sphere
growth and mounted into Vectashield reagent for imaging with a Zeiss
AxioImager.Z2 upright epifluorescence microscope. Z-stacks were imaged
with the 10× objective (EC Plan Neofluar, NA 0.3) using a digital camera
(Hamamatsu Orca Flash 4.0 LT). Images were processed with ZEN 2 pro
software (Zeiss) using extended depth-of-focus module (contrast function;
z-stack alignment: highest; contrast length scale 7; smoothing 11; reconstruction
0.15) for sharply extracting z-stacks for image quantification using the ImageJ
software. The growth of the PC3 tumor cell spheres was analyzed and the
Clustering Index was calculated to quantify the nonspreading, compact growth
of the PC3 tumor spheres in coculture with RhoA-KO fibroblasts. For the Clus-
tering Index, the level of sprouting was calculated (total n = 16 image fields,
from two independent repeats) and subtracted from a constant value: Clus-
tering Index = [20 − (mean number of sprouting growths)] ×5.
Atomic Force Microscopy.Atomic forcemicroscopy imagingwas performedusing
a JPK Nanowizard 3 system installed on an inverted optical microscope (Nikon
TE-1). The system was fitted with a Petri dish heater that held the cell-culture
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dishes in a 37 °C. Advanced QI Mode provided the possibility to rapidly collect
maps of approach-retract cycles (force curves) across the samples, from which
mechanical maps were constructed (46). Atomic force microscopy has a lateral
range of 100 μm and a vertical range of 15 μm, which is easily sufficient to
characterize the cells used in this study. A standard contact mode cantilever
(Bruker MLCT-E; nominal spring constant, 0.1 nm−1; resonance frequency,
50 kHz; tip radius, 20 nm) was calibrated in air before the measurements, by
first measuring the deflection sensitivity (nm/V) against a stiff polystyrene
substrate, and then fitting the fundamental resonance peak in the thermal
noise spectrum to determine the spring constant (47). This relatively stiff
cantilever was chosen to minimize the effects of bulk hydrodynamic drag,
while being soft enough to register differences in force and provide suffi-
ciently large indentations (hundreds of nanometers) that the cytoskeleton
controlled the stiffness. The cell dish was placed in the Petri dish heater, and
the head placed over it. Before acquiring images, the deflection sensitivity
was measured against a bare Petri dish with medium. Image resolution was
128 × 128 pixels. Approach and retract distances were set to 1.5 μm, and the
speed was set to 50 μm s−1. At this speed and resolution, the acquisition time
was around 20 min per image.
Each interaction can be considered as an indentation experiment from
which the effective Young’s modulus can be extracted (JPK Data Processing
software). The approach curve was first corrected for baseline position and
slope, and converted to force versus separation. The Hertz model was then
performed using square pyramidal indenter geometry, with an average
edge angle of 25°. A batch process was used to fit the 128 × 128 indentation
plots after optimizing the fitting parameters on a representative selection of
the data. Apart from the Young’s modulus, the contact position was also
determined via this fitting procedure (i.e., the height at which the fit to the
cantilever deflection deviated from zero).
Further image handling was performed in Gwyddion (gwyddion.net).
Modulus histograms for each image were prepared using 246 bins. Graphs
were prepared in Origin (OriginLab). There was a large variation between
cells, and one image of each cell shows the qualitative difference in stiffness
distribution over the cell (Fig. S6).
Traction Force Microscopy. Traction force microscopy calculations were per-
formed as previously described (48). A description may also be found in SI
Materials and Methods.
Affymetrix Microarrays. Four-day-old fibroblast monolayers were cocultured
with the PC3 mRFP prostate tumor cells, plated at a ratio of 1:30 according to
the number of plated fibroblasts. After 6 d of coculturing, the cells were
sorted by fluorescence-activated cell sorting. The total RNAwas isolated from
monocultured and cocultured cells using kits. Then, 150 ng total RNA was
used for the transcriptomic analysis.
Array hybridization, washing, staining, and scanning were performed
using the Affymetrix WT Plus labeling and hyb to the HG 2.1 ST Array plate.
Summary, normalization, and background correction were performed in
Affymetrix Expression Console (v1.3.1) using the robust multiarray average
method. The GEO accession number for the Affymetrix data is GSE83913 and
available at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83913.
Differential Expression Analysis. We compared expression in the following
contrasts of our interest: (i) BjhTERT before confrontation (control) vs.
BjhTERT before confrontation (knock-out); (ii) BjhTERT after confrontation
(control) vs. BjhTERT after confrontation (knock-out); and (iii) PC3 after
confrontation (control) vs. PC3 after confrontation (knock-out).
To increase confidence, we calculated fold-change values by using both
the wild-type control and the empty vector control as substitutes for
biological replicates.
For the NEA, we selected genes with twofold change in either direction the
“up” and “down” lists were treated separately. Fold-change values were
calculated as arithmetic differences between the log-transformed Affyme-
trix expression values obtained at the processing steps described in section
“Affymetrix microarrays” above.
Network Enrichment Analysis. As there were not enough replicated samples
for a detailed differentially expressed analysis at the level of the individual
genes, we used a new method of NEA (22) that estimates pathway enrich-
ment in differentially expressed gene lists in a more robust manner (49)
compared with both single-gene differential expression and the state-of-
the-art gene-set enrichment analysis (50).
NEA evaluates the network connectivity between experimentally defined
gene sets and some previously known or hypothesized gene sets with a clearly
defined function. The individual connections are edges (functional links) in
the global network between any of the genes of the former and latter gene
sets. As even spurious connections between randomgene sets can be found in
a dense network, the significance of each pattern is evaluated using a special
algorithm (22, 23).
The three components required for the network enrichment analysis were
provided as follows: (i) experimental gene sets that were created as differ-
entially expressed gene lists by comparing mRNA expression in KO cells with
that in both of the controls, before and after coculturing with the cancer
cells; (ii) functional genes sets (pathways of Gene Ontology terms); and (iii) a
global network of physical interactions and other functional coupling be-
tween genes and proteins that was created from a multifaceted data in-
tegration of high-throughput and curated resources, as described in ref. 51.
The current version included 19,027 genes (mapped to HUGO gene symbols)
with 947,000 links that connected them.
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